AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

Rhea-AI Summary

Amgen (NASDAQ: AMGN) has announced its participation in the 45th Annual TD Cowen Health Care Conference scheduled for March 5, 2025, at 9:10 a.m. ET. Jay Bradner, executive vice president of Research and Development, will engage in a fireside chat during the conference.

The presentation will be accessible through a live webcast available to investors, media, and the general public. The webcast can be accessed on www.amgen.com under the Investors section, along with other management presentations from investor and medical conferences. The webcast recording will remain available for replay for a minimum of 90 days following the event.

THOUSAND OAKS, Calif., Feb. 28, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 45^th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Wednesday, March 5, 2025. Jay Bradner, executive vice president of Research and Development at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. 

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. 

For more information, visit Amgen.com and follow us on X (formerly known as Twitter), LinkedIn, Instagram, YouTube and Threads. 

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media) 
Justin Claeys, 805-313-9775 (investors)   

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-45th-annual-td-cowen-health-care-conference-302388840.html

SOURCE Amgen

FAQ

When is Amgen (AMGN) presenting at the TD Cowen Health Care Conference 2025?

Amgen will present on Wednesday, March 5, 2025, at 9:10 a.m. ET at the 45th Annual TD Cowen Health Care Conference.

Who will represent AMGN at the 2025 TD Cowen Health Care Conference?

Jay Bradner, Executive Vice President of Research and Development at Amgen, will participate in a fireside chat.

How can investors watch Amgen's (AMGN) TD Cowen Conference presentation?

The presentation will be available via live webcast on Amgen's website (www.amgen.com) under the Investors section.

How long will AMGN's TD Cowen Conference webcast be available for replay?

The webcast will be archived and available for replay for at least 90 days after the event.